GAFFX
Price
$77.04
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
STCAX
Price
$14.63
Change
-$0.05 (-0.34%)
Updated
Sep 20 closing price
Ad is loading...

GAFFX vs STCAX

Header iconGAFFX vs STCAX Comparison
Open Charts GAFFX vs STCAXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.04
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
Virtus Silvant Large-Cap Growth Stk I
Price$14.63
Change-$0.05 (-0.34%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GAFFX vs STCAX Comparison Chart
Loading...
VS
GAFFX vs. STCAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and STCAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 290B vs. STCAX (188M). GAFFX pays higher dividends than STCAX: GAFFX (0.75) vs STCAX (0.00). GAFFX was incepted earlier than STCAX: GAFFX (8 years) vs STCAX (32 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. STCAX (17.00). STCAX has a lower initial minimum investment than GAFFX: STCAX (100000) vs GAFFX (1000000). STCAX annual gain was more profitable for investors over the last year : 40.13 vs. GAFFX (30.65). STCAX return over 5 years is better than : 84.96 vs. GAFFX (55.06).
GAFFXSTCAXGAFFX / STCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years32 years-
Gain YTD21.99524.93688%
Front LoadN/AN/A-
Min. Initial Investment10000001000001,000%
Min. Initial Investment IRAN/AN/A-
Net Assets290B188M154,255%
Annual Yield % from dividends0.750.00-
Returns for 1 year30.6540.1376%
Returns for 3 years1.2826.455%
Returns for 5 years55.0684.9665%
Returns for 10 yearsN/A43.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TEF4.83N/A
N/A
Telefonica SA
SANM69.03-0.65
-0.93%
Sanmina Corp
ACRV7.47-0.12
-1.58%
Acrivon Therapeutics
PGRE5.02-0.15
-2.90%
Paramount Group
CGTX0.58-0.03
-4.89%
Cognition Therapeutics